Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Circadian regulation of lung repair and regeneration
Amruta Naik, Kaitlyn M. Forrest, Oindrila Paul, Yasmine Issah, Utham K. Valekunja, Soon Y. Tang, Akhilesh B. Reddy, Elizabeth J. Hennessy, Thomas G. Brooks, Fatima Chaudhry, Apoorva Babu, Michael Morley, Jarod A. Zepp, Gregory R. Grant, Garret A. FitzGerald, Amita Sehgal, G. Scott Worthen, David B. Frank, Edward E. Morrisey, Shaon Sengupta
Amruta Naik, Kaitlyn M. Forrest, Oindrila Paul, Yasmine Issah, Utham K. Valekunja, Soon Y. Tang, Akhilesh B. Reddy, Elizabeth J. Hennessy, Thomas G. Brooks, Fatima Chaudhry, Apoorva Babu, Michael Morley, Jarod A. Zepp, Gregory R. Grant, Garret A. FitzGerald, Amita Sehgal, G. Scott Worthen, David B. Frank, Edward E. Morrisey, Shaon Sengupta
View: Text | PDF | Corrigendum
Research Article Pulmonology Virology

Circadian regulation of lung repair and regeneration

  • Text
  • PDF
Abstract

Optimal lung repair and regeneration are essential for recovery from viral infections, including influenza A virus (IAV). We have previously demonstrated that acute inflammation and mortality induced by IAV is under circadian control. However, it is not known whether the influence of the circadian clock persists beyond the acute outcomes. Here, we utilize the UK Biobank to demonstrate an association between poor circadian rhythms and morbidity from lower respiratory tract infections, including the need for hospitalization and mortality after discharge; this persists even after adjusting for common confounding factors. Furthermore, we use a combination of lung organoid assays, single-cell RNA sequencing, and IAV infection in different models of clock disruption to investigate the role of the circadian clock in lung repair and regeneration. We show that lung organoids have a functional circadian clock and the disruption of this clock impairs regenerative capacity. Finally, we find that the circadian clock acts through distinct pathways in mediating lung regeneration — in tracheal cells via the Wnt/β-catenin pathway and through IL-1β in alveolar epithelial cells. We speculate that adding a circadian dimension to the critical process of lung repair and regeneration will lead to novel therapies and improve outcomes.

Authors

Amruta Naik, Kaitlyn M. Forrest, Oindrila Paul, Yasmine Issah, Utham K. Valekunja, Soon Y. Tang, Akhilesh B. Reddy, Elizabeth J. Hennessy, Thomas G. Brooks, Fatima Chaudhry, Apoorva Babu, Michael Morley, Jarod A. Zepp, Gregory R. Grant, Garret A. FitzGerald, Amita Sehgal, G. Scott Worthen, David B. Frank, Edward E. Morrisey, Shaon Sengupta

×

Figure 2

Infection time of day affects long-term lung repair and regeneration.

Options: View larger image (or click on image) Download as PowerPoint
Infection time of day affects long-term lung repair and regeneration.
(A...
(A) Schematic of experimental design: Mice were infected with influenza A virus (IAV) at either dawn (ZT23/rest phase) or dusk (ZT11/active phase). (B) Left: Representative micrographs of H&E-stained lung sections 30 days post infection (p.i.). The red box denotes areas with maximal alveolar destruction — zones 3 and 4 in our scoring system. Scale bars: 5–6 mm. Right: Quantification of the severity of lung injury. **P = 0.0029 for time of infection by 2-way ANOVA. *P = 0.016 for zone 3 and **P = 0.04 for zone 4 on multiple comparison with Bonferroni’s correction. (C) Pulse oximetry on day 35 p.i. ****P < 0.0001 by unpaired 2-tailed t test. (D) Left: Representative micrographs of H&E-stained lung sections from Bmal1creERT2/+ and creneg littermates 30 days p.i. Scale bars: 5–6 mm. Right: Quantification. *P = 0.0028 for time of infection, 2-way ANOVA. *P = 0.0171 for zone 3 and **P = 0.0056 for zone 4 on multiple comparison with Bonferroni’s correction. Data were pooled from 2–4 independent experiments and are represented as mean ± SEM. (E) Pulse oximetry on day 35 p.i. **P = 0.0061 by Mann-Whitney test. (F) Experimental design for organotypic assays. (G) Representative tracing of relative bioluminescence of Per2 expression in organoids grown from different levels of respiratory tree from mPer2Luc mice. (H) Relative bioluminescence recording of tracheal organoids 4 days after seeding. Organoid data are summarized from 3–5 independent experiments with at least 3 technical replicates/experiment. Two-way ANOVA with Tukey’s multiple-comparisons test. **P = 0.009, 0.004, 0.005; hours of bioluminescence **P = 0.0019.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts